Antimicrobial antagonists against food pathogens: A bacteriocin perspective

Current Opinion in Food Science

Volumn 2, Issue , 2015, Pages 51-57

  O'Connor, Paula M ^a,c   Ross, R Paul ^b,c   Hill, Colin ^b,c   Cotter, Paul D ^a,c  

^a TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84923052785     PISSN: 22147993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cofs.2015.01.004     Document Type: Review

References (59)

1. Mills S., Stanton C., Hill C., Ross R.P. New developments and applications of bacteriocins and peptides in foods. Annu Rev Food Sci Technol 2011, 2:299-329.
2. Deegan L.H., Cotter P.D., Hill C., Ross P. Bacterlocins: biological tools for bio-preservation and shelf-life extension. Int Dairy J 2006, 16:1058-1071.
3. Ghanbari M., Jami M., Domig K.J., Kneifel W. Seafood biopreservation by lactic acid bacteria-a review. LWT-Food Sci Technol 2013, 54:315-324.
4. Snyder A.B., Worobo R.W. Chemical and genetic characterization of bacteriocins: antimicrobial peptides for food safety. J Sci Food Agric 2014, 94:28-44.
5. Galvez A., Abriouel H., Benomar N., Lucas R. Microbial antagonists to food-borne pathogens and biocontrol. Curr Opin Biotechnol 2010, 21:142-148.
6. Nishie M., Nagao J., Sonomoto K. Antibacterial peptides "bacteriocins": an overview of their diverse characteristics and applications. Biocontrol Sci 2012, 17:1-16.
7. Cotter P.D., Ross R.P., Hill C. Bacteriocins-a viable alternative to antibiotics?. Nat Rev Microbiol 2013, 11:95-105.
8. Davidson P.M., Critzer F.J., Taylor T.M. Naturally occurring antimicrobials for minimally processed foods. Annu Rev Food Sci Technol 2013, 4:163-190.
9. Cotter P.D., Hill C., Ross R.P. Bacteriocins: developing innate immunity for food. Nat Rev Microbiol 2005, 3:777-788.
10. Martin-Visscher L.A., Yoganathan S., Sit C.S., Lohans C.T., Vederas J.C. The activity of bacteriocins from Carnobacterium maltaromaticum UAL307 against gram-negative bacteria in combination with EDTA treatment. FEMS Microbiol Lett 2011, 317:152-159.
11. Masuda Y., Zendo T., Sawa N., Perez R.H., Nakayama J., Sonomoto K. Characterization and identification of weissellicin Y and weissellicin M, novel bacteriocins produced by Weissella hellenica QU 13. J Appl Microbiol 2012, 112:99-108.
12. Maldonado-Barragan A., Cardenas N., Martinez B., Ruiz-Barba J.L., Fernandez-Garayzabal J.F., Rodriguez J.M., Gibello A. Garvicin A, a novel class IId bacteriocin from Lactococcus garvieae that inhibits septum formation in L. garvieae strains. Appl Environ Microbiol 2013, 79:4336-4346.
13. Tosukhowong A., Zendo T., Visessanguan W., Roytrakul S., Pumpuang L., Jaresitthikunchai J., Sonomoto K. Garvieacin Q, a novel class II bacteriocin from Lactococcus garvieae BCC 43578. Appl Environ Microbiol 2012, 78:1619-1623.
14. Sawa N., Wilaipun P., Kinoshita S., Zendo T., Leelawatcharamas V., Nakayama J., Sonomoto K. Isolation and characterization of enterocin W, a novel two-peptide lantibiotic produced by Enterococcus faecalis NKR-4-1. Appl Environ Microbiol 2012, 78:900-903.
15. O'Shea E.F., O'Connor P.M., O'Sullivan O., Cotter P.D., Ross R.P., Hill C. Bactofencin A, a new type of cationic bacteriocin with unusual immunity. MBio 2013, 4:e00498-13.
16. Ishibashi N., Himeno K., Fujita K., Masuda Y., Perez R.H., Zendo T., Wilaipun P., Leelawatcharamas V., Nakayama J., Sonomoto K. Purification and characterization of multiple bacteriocins and an inducing peptide produced by Enterococcus faecium NKR-5-3 from Thai fermented fish. Biosci Biotechnol Biochem 2012, 76:947-953.
17. Himeno K., Fujita K., Zendo T., Wilaipun P., Ishibashi N., Masuda Y., Yoneyama F., Leelawatcharamas V., Nakayama J., Sonomoto K. Identification of enterocin NKR-5-3C, a novel class IIa bacteriocin produced by a multiple bacteriocin producer, Enterococcus faecium NKR-5-3. Biosci Biotechnol Biochem 2012, 76:1245-1247.
18. Masuda Y., Zendo T., Sonomoto K. New type non-lantibiotic bacteriocins: circular and leaderless bacteriocins. Benef Microbes 2012, 3:3-12.
19. Montalban-Lopez M., Sanchez-Hidalgo M., Cebrian R., Maqueda M. Discovering the bacterial circular proteins: bacteriocins, cyanobactins, and pilins. J Biol Chem 2012, 287:27007-27013.
20. Gabrielsen C., Brede D.A., Nes I.F., Diep D.B. Circular bacteriocins: biosynthesis and mode of action. Appl Environ Microbiol 2014, 80:6854-6862.
21. Borrero J., Brede D.A., Skaugen M., Diep D.B., Herranz C., Nes I.F., Cintas L.M., Hernandez P.E. Characterization of garvicin ML, a novel circular bacteriocin produced by Lactococcus garvieae DCC43, isolated from mallard ducks (Anas platyrhynchos). Appl Environ Microbiol 2011, 77:369-373.
22. Masuda Y., Ono H., Kitagawa H., Ito H., Mu F., Sawa N., Zendo T., Sonomoto K. Identification and characterization of leucocyclicin Q, a novel cyclic bacteriocin produced by Leuconostoc mesenteroides TK41401. Appl Environ Microbiol 2011, 77:8164-8170.
23. Liu X., Basu U., Miller P., McMullen L.M. Stress response and adaptation of Listeria monocytogenes 08-5923 exposed to a sublethal dose of carnocyclin A. Appl Environ Microbiol 2014, 80:3835-3841.
24. Oshima S., Rea M.C., Lothe S., Morgan S., Begley M., O'Connor P.M., Fitzsimmons A., Kamikado H., Walton R., Ross R.P., et al. Efficacy of organic acids, bacteriocins, and the lactoperoxidase system in inhibiting the growth of Cronobacter spp. in rehydrated infant formula. J Food Prot 2012, 75:1734-1742.
25. Karam L., Jama C., Mamede A.S., Boukla S., Dhulster P., Chihib N.E. Nisin-activated hydrophobic and hydrophilic surfaces: assessment of peptide adsorption and antibacterial activity against some food pathogens. Appl Microbiol Biotechnol 2013, 97:10321-10328.
26. Blanco Massani M., Botana A., Eisenberg P., Vignolo G. Development of an active wheat gluten film with Lactobacillus curvatus CRL705 bacteriocins and a study of its antimicrobial performance during ageing. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2014, 31:164-171.
27. Blanco Massani M., Molina V., Sanchez M., Renaud V., Eisenberg P., Vignolo G. Active polymers containing Lactobacillus curvatus CRL705 bacteriocins: effectiveness assessment in Wieners. Int J Food Microbiol 2014, 178:7-12.
28. Caballero Gomez N.C., Abriouel H., Grande M.A., Pulido R.P., Galvez A. Effect of enterocin AS-48 in combination with biocides on planktonic and sessile Listeria monocytogenes. Food Microbiol 2012, 30:51-58.
29. Caballero Gomez N., Abriouel H., Ennahar S., Galvez A. Comparative proteomic analysis of Listeria monocytogenes exposed to enterocin AS-48 in planktonic and sessile states. Int J Food Microbiol 2013, 167:202-207.
30. Aboye T.L., Camarero J.A. Biological synthesis of circular polypeptides. J Biol Chem 2012, 287:27026-27032.
31. Molloy E.M., Ross R.P., Hill C. 'Bac' to the future: bioengineering lantibiotics for designer purposes. Biochem Soc Trans 2012, 40:1492-1497.
32. Field D., Begley M., O'Connor P.M., Daly K.M., Hugenholtz F., Cotter P.D., Hill C., Ross R.P. Bioengineered nisin A derivatives with enhanced activity against both Gram positive and Gram negative pathogens. PLoS One 2012, 7:e46884.
33. Molloy E.M., Field D.P.M., Cotter O.C., Hill P.D., Ross C.R.P. Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity. PLoS One 2013, 8:e58530.
34. Yuan J., Zhang Z.Z., Chen X.Z., Yang W., Huan L.D. Site-directed mutagenesis of the hinge region of nisinZ and properties of nisinZ mutants. Appl Microbiol Biotechnol 2004, 64:806-815.
35. Rouse S., Field D., Daly K.M., O'Connor P.M., Cotter P.D., Hill C., Ross R.P. Bioengineered nisin derivatives with enhanced activity in complex matrices. Microb Biotechnol 2012, 5:501-508.
36. Healy B., Field D., O'Connor P.M., Hill C., Cotter P.D., Ross R.P. Intensive mutagenesis of the nisin hinge leads to the rational design of enhanced derivatives. PLoS One 2013, 8:e79563.
37. Boakes S., Ayala T., Herman M., Appleyard A.N., Dawson M.J., Cortes J. Generation of an actagardine A variant library through saturation mutagenesis. Appl Microbiol Biotechnol 2012, 95:1509-1517.
38. Acuna L., Picariello G., Sesma F., Morero R.D., Bellomio A. A new hybrid bacteriocin, Ent35-MccV, displays antimicrobial activity against pathogenic Gram-positive and Gram-negative bacteria. FEBS Open Bio 2012, 2:12-19.
39. Tabor A.B. Recent advances in synthetic analogues of lantibiotics: what can we learn from these?. Bioorg Chem 2014, 55:39-50.
40. Montalban-Lopez M., Zhou L., Buivydas A., van Heel A.J., Kuipers O.P. Increasing the success rate of lantibiotic drug discovery by synthetic biology. Expert Opin Drug Discov 2012, 7:695-709.
41. Knerr P.J., van der Donk W.A. Chemical synthesis of the lantibiotic lacticin 481 reveals the importance of lanthionine stereochemistry. J Am Chem Soc 2013, 135:7094-7097.
42. Kong W., Lu T. Cloning and optimization of a nisin biosynthesis pathway for bacteriocin harvest. ACS Synth Biol 2014, 3:439-445.
43. Jimenez J.J., Borrero J., Gutiez L., Arbulu S., Herranz C., Cintas L.M., Hernandez P.E. Use of synthetic genes for cloning, production and functional expression of the bacteriocins enterocin A and bacteriocin E 50-52 by Pichia pastoris and Kluyveromyces lactis. Mol Biotechnol 2014, 56:571-583.
44. Sandiford S.K. Advances in the arsenal of tools available enabling the discovery of novel lantibiotics with therapeutic potential. Expert Opin Drug Discov 2014, 9:283-297.
45. Marsh A.J., Hill C., Ross R.P., Cotter P.D. Strategies to identify modified ribosomally synthesized antimicrobials 2012, 166-186. Antimicrobial Drug Discovery: Emerging Strategies. G. Tegos, E. Mylonakis (Eds.).
46. van Heel A.J., de Jong A., Montalban-Lopez M., Kok J., Kuipers O.P. BAGEL3: automated identification of genes encoding bacteriocins and (non-)bactericidal posttranslationally modified peptides. Nucleic Acids Res 2012, 41:W448-W453.
47. Hammami R., Fernandez B., Lacroix C., Fliss I. Anti-infective properties of bacteriocins: an update. Cell Mol Life Sci 2013, 70:2947-2967.
48. Kersten R.D., Yang Y.L., Xu Y., Cimermancic P., Nam S.J., Fenical W., Fischbach M.A., Moore B.S., Dorrestein P.C. A mass spectrometry-guided genome mining approach for natural product peptidogenomics. Nat Chem Biol 2011, 7:794-802.
49. Zendo T. Screening and characterization of novel bacteriocins from lactic acid bacteria. Biosci Biotechnol Biochem 2013, 77:893-899.
50. Perez R.H., Zendo T., Sonomoto K. Novel bacteriocins from lactic acid bacteria (LAB): various structures and applications. Microb Cell Fact 2014, 13(Suppl 1):S3.
51. Wang J., Zhang L., Teng K., Sun S., Sun Z., Zhong J. Cerecidins, novel lantibiotics from Bacillus cereus with potent antimicrobial activity. Appl Environ Microbiol 2014, 80:2633-2643.
52. Dobson A., Cotter P.D., Ross R.P., Hill C. Bacteriocin production: a probiotic trait?. Appl Environ Microbiol 2012, 78:1-6.
53. Lakshminarayanan B., Guinane C.M., O'Connor P.M., Coakley M., Hill C., Stanton C., O'Toole P.W., Ross R.P. Isolation and characterization of bacteriocin-producing bacteria from the intestinal microbiota of elderly Irish subjects. J Appl Microbiol 2013, 114:886-898.
54. Selle K., Klaenhammer T.R. Genomic and phenotypic evidence for probiotic influences of Lactobacillus gasseri on human health. FEMS Microbiol Rev 2013, 37:915-935.
55. Riboulet-Bisson E., Sturme M.H., Jeffery I.B., O'Donnell M.M., Neville B.A., Forde B.M., Claesson M.J., Harris H., Gardiner G.E., Casey P.G., et al. Effect of Lactobacillus salivarius bacteriocin Abp118 on the mouse and pig intestinal microbiota. PLoS One 2012, 7:e31113.
56. Murphy E.F., Cotter P.D., Hogan A., O'Sullivan O., Joyce A., Fouhy F., Clarke S.F., Marques T.M., O'Toole P.W., Stanton C., et al. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut 2013, 62:220-226.
57. Miyauchi E., O'Callaghan J., Butto L.F., Hurley G., Melgar S., Tanabe S., Shanahan F., Nally K., O'Toole P.W. Mechanism of protection of transepithelial barrier function by Lactobacillus salivarius: strain dependence and attenuation by bacteriocin production. Am J Physiol Gastrointest Liver Physiol 2012, 303:G1029-G1041.
58. Munoz-Atienza E., Gomez-Sala B., Araujo C., Campanero C., del Campo R., Hernandez P.E., Herranz C., Cintas L.M. Antimicrobial activity, antibiotic susceptibility and virulence factors of Lactic Acid Bacteria of aquatic origin intended for use as probiotics in aquaculture. BMC Microbiol 2013, 13:15.
59. Rea M.C., Alemayehu D., Casey P.G., O'Connor P.M., Lawlor P.G., Walsh M., Shanahan F., Kiely B., Ross R.P., Hill C. Bioavailability of the anti-clostridial bacteriocin thuricin CD in gastrointestinal tract. Microbiology 2014, 160:439-445.